Nona Biosciences’ Global License and Option Agreement with AstraZeneca

Leila Ahmed North America Legal Chronicle
Tagged:

Ropes & Gray advised Nona Biosciences on the deal.Nona Biosciences announced it has entered into a license agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) for preclinical monoclonal antibodies…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here